The American Journal of Emergency Medicine is a peer-reviewed medical journal, covering emergency medicine.
(HealthDay)—The COVID-19 pandemic has had far-reaching effects, and a new study points to yet another: It may be keeping people from seeking emergency care for suicidal thoughts.
Jun 08, 2020
0
8
In a study published in the American Journal of Emergency Medicine, Mount Sinai researchers describe some of the earliest cases of a COVID-19-related illness newly identified by the U.S. Centers for Disease Control (CDC) ...
May 29, 2020
0
1
COVID-19 can cause serious cardiovascular complications including heart failure, heart attacks and blood clots that can lead to strokes, emergency medicine doctors report in a new scientific paper. They also caution that ...
May 15, 2020
0
64
A new study led by fellows at the USC Schaeffer Center shows mental health-related emergency department (ED) visits have increased substantially since 2009, a trend driven by large increases in adolescent and young adult ...
Jan 27, 2020
0
6
In a new study published in the American Journal of Emergency Medicine, Adam Singer, MD, et al reported that quickly correcting high potassium levels, a condition known as hyperkalemia, in emergency department patients cut ...
Jan 08, 2020
0
0
Free-standing emergency departments (EDs) in Texas' largest cities have not alleviated emergency room congestion or improved patient wait times in nearby hospitals, according to a new paper by experts at Rice University.
May 21, 2019
0
1
In a recent Rutgers study, 38 percent of patients discharged from the emergency department had at least one drug interaction resulting from a newly prescribed medicine.
Feb 26, 2019
0
1
Widespread methamphetamine use is creating a unique form of severe heart failure, according to new research that shows these patients tend to be younger and have poor outcomes.
Nov 06, 2018
0
41
A new study has shown that use of peripheral nerve blocks in the treatment of Trigeminal Neuralgia (TGN) may produce long-term pain relief.
Aug 13, 2018
0
1
Ischemic stroke patients who do not receive intravelous (IV) alteplase, a clot-dissolving medication, are significantly less likely to survive, according to researchers at Georgia State University.
Oct 05, 2017
0
347
